Urolithin A vs PQQ: How They Compare

Urolithin A and PQQ are both marketed for mitochondrial health, so it is easy to assume they do the same thing. They don't. One helps your cells recycle worn-out mitochondria; the other is associated with helping cells build new ones. Here is an evidence-first comparison of how they differ, what the research actually shows, and how to choose.

The quick version

Urolithin A is a gut postbiotic that supports mitophagy — the housekeeping process that clears away damaged mitochondria. PQQ (pyrroloquinoline quinone) is a small redox-active compound most often linked to mitochondrial biogenesis, the making of new mitochondria, along with antioxidant activity. In other words, one is largely about renewal and cleanup, the other largely about building and protecting. The other major difference is the depth of human evidence: urolithin A has several published human trials, while PQQ's human data is more limited and much of its mechanism rests on cell and animal work.

How urolithin A works

You do not eat urolithin A directly. It is created when gut microbes convert ellagitannins — compounds in pomegranates, walnuts and berries — into urolithins. Only some people carry the microbiome to produce meaningful amounts, which is a large part of why the finished molecule is supplemented. Its defining role is supporting mitophagy: tagging aged, dysfunctional mitochondria for recycling so healthier ones can take over. Our urolithin A guide goes deeper on the biology, and our mitochondrial health overview puts it in context.

The human evidence for urolithin A

The mitophagy mechanism has been examined in people, which is what distinguishes urolithin A here. Andreux and colleagues (2019, Nature Metabolism) ran the first-in-human trial and reported it safe and well tolerated up to 1,000 mg per day, with a favorable mitochondrial gene-expression signature. Liu, D'Amico and colleagues (2022, JAMA Network Open) reported improved muscle endurance — contractions before fatigue — in older adults over about four months. Singh and colleagues (2022, Cell Reports Medicine) tested 500 mg and 1,000 mg arms in middle-aged adults over four months and reported gains in muscle strength and exercise performance. A 2025 Nature Aging randomized trial (about 28 days) reported support for immune-cell mitochondrial health in midlife adults, and a 2024 trial in the Journal of the International Society of Sports Nutrition looked at endurance and recovery in resistance-trained men.

What is still preclinical for urolithin A

The foundational mitophagy and lifespan findings (Ryu and colleagues, 2016, Nature Medicine) are from animal and cell research, not human proof, as is the joint and cartilage work (D'Amico and colleagues, 2022, Aging Cell). A 2024 systematic review in Ageing Research Reviews described the human evidence as promising but still emerging, from short trials of modest size — a fair and honest summary.

How PQQ works

PQQ is a small quinone that acts as a redox cofactor, meaning it can cycle between oxidized and reduced forms and participate in electron-transfer reactions. It is found in trace amounts in foods such as fermented soy, parsley and green tea. Its most-cited mechanism comes from cell research: PQQ has been reported to stimulate mitochondrial biogenesis by activating signaling through CREB and PGC-1alpha, master regulators that switch on genes for building new mitochondria. It also has direct antioxidant properties, helping neutralize reactive molecules. Our primer on what PQQ is covers the details.

The evidence for PQQ

Most of PQQ's mechanistic story is preclinical. The biogenesis findings (for example, the 2010 work showing PGC-1alpha activation) come from cell and rodent studies, not human proof, and animal research has explored PQQ in the context of oxidative stress and aging markers. Human data exists but is limited: small trials have looked at outcomes like fatigue, sleep quality and some cognitive measures, generally with modest sample sizes and short durations. Compared with urolithin A's muscle and mitochondrial trials, PQQ's controlled human evidence is thinner. It remains a biologically interesting compound whose promise currently outpaces its human proof.

Recycling vs building: the core contrast

The cleanest way to separate these two is the phrase mitochondrial quality control versus mitochondrial quantity. Urolithin A leans toward quality control — helping cells remove mitochondria that no longer perform. PQQ is associated with the quantity and protection side — signaling for new mitochondria to form and buffering oxidative stress. A healthy mitochondrial network depends on both processes staying in balance, which is precisely why these two ingredients are often discussed together rather than as rivals.

Are they complementary?

Conceptually they are among the more logical pairings in the mitochondrial category, because renewal (urolithin A) and biogenesis plus antioxidant support (PQQ) address different, arguably complementary, parts of the same system. However — and this matters — no robust human trial has tested the two together, so any combined benefit is a reasonable hypothesis, not a demonstrated result. Both are structure/function ingredients for general wellness, not treatments for fatigue, cognitive conditions or any disease. If you take medication, are pregnant, or are managing a health concern, that is a conversation to have with your doctor before combining supplements.

How to choose by goal

Choose urolithin A if…

You want the ingredient with the most human evidence in this comparison, particularly for muscle endurance, strength and exercise recovery, and you value that the mitophagy mechanism has been tested in multiple clinical trials. It is also a natural pick if you suspect your microbiome does not convert dietary ellagitannins well. See the best urolithin A gummies and our notes on urolithin A for energy.

Choose PQQ if…

You are specifically drawn to the biogenesis-and-antioxidant angle and are comfortable acting on evidence that is largely preclinical, with only small human trials so far. PQQ tends to appeal to people building a broader mitochondrial or cognitive-support stack.

Or start with the better-evidenced option

If your goal is the strongest current human data for mitochondrial and muscle support, urolithin A is the more established choice today. Our dosage guide covers the studied 500–1,000 mg range.

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This guide is educational and is not a substitute for advice from a qualified healthcare provider.